Amicus Therapeutics Inc. buy Citigroup Inc.
Start price
17.12.25
/
50%
€9.40
Target price
17.12.26
€14.47
Performance (%)
30.37%
Price
21.04.26
€12.15
Summary
This prediction is currently active. With a performance of 30.37% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 17.12.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | 0.082% | 0.082% |
| iShares Core DAX® | 0,08 % | 8,29 % |
| iShares Nasdaq 100 | 3,10 % | 8,87 % |
| iShares Nikkei 225® | -0,48 % | 12,65 % |
| iShares S&P 500 | 1,99 % | 6,69 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics (NASDAQ:FOLD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $17.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat